Home  >  Products  >  DGCR8 (DiGeorge syndrome critical region gene 8) Blocking Peptide (the N terminal of protein) (100ug)
DGCR8 (DiGeorge syndrome critical region gene 8) Blocking Peptide (the N terminal of protein) (100ug)

DGCR8 (DiGeorge syndrome critical region gene 8) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DGCR8 antibody (Catalogue #: ARP40984_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP40984
Size: 100 ug
Weight: 85kDa
Gene: 54487
Format: Lyophilized powder
Target: DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
Alternative names: C22orf12; DGCRK6; Gy1
See Full Product Listings >